Healthcare

Clover Corporation Limited (ASX:CLV) is an Australian food ingredients company specialising in omega-3 oils and nutritional solutions. The company focuses on refining and processing DHA oils, which are used by manufacturers of infant formula, nutritional supplements and other food products. This article examines Clover'sBusinessmodel, …

Neurotech International Limited (ASX:NTI) is a Melbourne-based clinical-stage biopharmaceutical company developing NTI164, a cannabinoid-based drug candidate for childhood neurological conditions. The company's lead programme focuses on autism spectrum disorder and has progressed from earlier clinical studies into a larger Phase 3 development pathway. This …

Optiscan Imaging Limited (ASX:OIL) is an Australian medical technology company developing advanced imaging systems that allow microscopic views of living tissue without traditional slide preparation. The company's technology is designed for research, pathology and surgical applications. This article examines Optiscan's imaging platform, clinical development …

Nanollose Limited (ASX:NC6) is an Australian biomaterials company developing microbial cellulose technology for fibre production. The company's flagship Nullarbor product is designed as an alternative approach to traditional cellulose-based fibres. This article examines Nanollose's technology platform, commercial development activities and the challenges involved in …

Algorae Pharmaceuticals Limited (ASX:1AI) describes itself as an Australian pharmaceutical company operating across commercial medicineSupplyand research and development. Its commercial division sources, registers and supplies generic and specialty medicines, while AlgoraeOS is the company's proprietary AI-powered drug discovery platform. The currentInvestmentnarrative therefore combines near-term …

Avecho Biotechnology Limited (ASX:AVE) is an Australian biotechnology company focused on drug delivery technology and pharmaceutical development. The company’s lead programme is an oral cannabidiol capsule being evaluated for insomnia, supported by its proprietary TPM delivery platform. This article examines Avecho’s clinical programme, delivery …

Patrys Limited (ASX:PAB) is an Australian biotechnology company developing RLS-2202, an injectable formulation of quetiapine for potential use in hospital patients with delirium. The company has shifted its focus towards drug repurposing and formulation development. This article examines Patrys’ new strategy, clinical pathway and …